Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mitral Valve Insufficiency | 122 | 2024 | 1415 | 13.650 |
Why?
|
Mitral Valve | 99 | 2025 | 1475 | 8.020 |
Why?
|
Mitral Valve Prolapse | 41 | 2025 | 213 | 7.590 |
Why?
|
Echocardiography, Three-Dimensional | 42 | 2021 | 615 | 3.850 |
Why?
|
Papillary Muscles | 30 | 2023 | 192 | 3.180 |
Why?
|
Ventricular Remodeling | 34 | 2024 | 1282 | 2.500 |
Why?
|
Mitral Valve Stenosis | 13 | 2023 | 342 | 2.130 |
Why?
|
Myocardial Ischemia | 24 | 2021 | 2139 | 1.970 |
Why?
|
Sheep | 35 | 2022 | 1451 | 1.900 |
Why?
|
Echocardiography, Doppler | 26 | 2020 | 898 | 1.670 |
Why?
|
Chordae Tendineae | 8 | 2023 | 39 | 1.600 |
Why?
|
Heart Valve Diseases | 17 | 2024 | 1030 | 1.590 |
Why?
|
Echocardiography | 36 | 2025 | 5046 | 1.510 |
Why?
|
Myocardial Infarction | 33 | 2022 | 11521 | 1.400 |
Why?
|
Mitral Valve Annuloplasty | 9 | 2024 | 145 | 1.270 |
Why?
|
Echocardiography, Doppler, Color | 16 | 2019 | 353 | 1.220 |
Why?
|
Ventricular Dysfunction, Left | 23 | 2020 | 2145 | 1.150 |
Why?
|
Rheumatic Heart Disease | 5 | 2024 | 164 | 1.150 |
Why?
|
Ventricular Function, Left | 30 | 2024 | 3941 | 0.890 |
Why?
|
Aortic Valve Stenosis | 11 | 2023 | 2034 | 0.820 |
Why?
|
Cardiomyopathy, Hypertrophic | 6 | 2019 | 1335 | 0.800 |
Why?
|
Tinnitus | 5 | 2012 | 197 | 0.770 |
Why?
|
Ventricular Function | 2 | 2017 | 406 | 0.730 |
Why?
|
Heart Atria | 11 | 2024 | 1360 | 0.730 |
Why?
|
Tricuspid Valve Insufficiency | 5 | 2023 | 362 | 0.720 |
Why?
|
Aortic Valve | 10 | 2023 | 1969 | 0.670 |
Why?
|
Heart Ventricles | 15 | 2023 | 3840 | 0.660 |
Why?
|
Imaging, Three-Dimensional | 9 | 2017 | 4077 | 0.660 |
Why?
|
Systole | 8 | 2020 | 937 | 0.630 |
Why?
|
Hemodynamics | 16 | 2022 | 4199 | 0.620 |
Why?
|
Fibrosis | 11 | 2023 | 2081 | 0.610 |
Why?
|
Echocardiography, Transesophageal | 8 | 2021 | 1096 | 0.600 |
Why?
|
Adaptation, Physiological | 7 | 2018 | 1315 | 0.590 |
Why?
|
Heart Valve Prosthesis | 8 | 2024 | 1468 | 0.570 |
Why?
|
Cardiac Resynchronization Therapy | 3 | 2019 | 560 | 0.570 |
Why?
|
Heart Valve Prosthesis Implantation | 9 | 2023 | 1568 | 0.570 |
Why?
|
Atrial Function | 1 | 2017 | 98 | 0.570 |
Why?
|
Myocardial Contraction | 11 | 2016 | 1526 | 0.550 |
Why?
|
Hypertension, Pulmonary | 3 | 2022 | 1600 | 0.520 |
Why?
|
Polyvinyl Alcohol | 3 | 2015 | 74 | 0.510 |
Why?
|
Stroke Volume | 24 | 2023 | 5621 | 0.500 |
Why?
|
Calcinosis | 5 | 2024 | 1481 | 0.480 |
Why?
|
Exercise Test | 9 | 2020 | 2187 | 0.470 |
Why?
|
Atrial Fibrillation | 7 | 2023 | 5176 | 0.450 |
Why?
|
Dust | 1 | 2016 | 488 | 0.440 |
Why?
|
Aortic Valve Insufficiency | 6 | 2020 | 577 | 0.430 |
Why?
|
Prolapse | 3 | 2023 | 63 | 0.430 |
Why?
|
Atrial Function, Left | 4 | 2023 | 188 | 0.430 |
Why?
|
Humans | 174 | 2025 | 768887 | 0.420 |
Why?
|
Echocardiography, Doppler, Pulsed | 3 | 2019 | 69 | 0.420 |
Why?
|
Ventricular Function, Right | 5 | 2018 | 628 | 0.420 |
Why?
|
Cardiac Imaging Techniques | 1 | 2015 | 281 | 0.400 |
Why?
|
Myocardial Perfusion Imaging | 5 | 2019 | 672 | 0.390 |
Why?
|
Predictive Value of Tests | 24 | 2023 | 15471 | 0.380 |
Why?
|
Coronary Circulation | 4 | 2016 | 1617 | 0.370 |
Why?
|
Male | 122 | 2025 | 365249 | 0.360 |
Why?
|
Endothelial Cells | 7 | 2022 | 3591 | 0.360 |
Why?
|
Disease Models, Animal | 17 | 2018 | 18366 | 0.350 |
Why?
|
Vascular Resistance | 1 | 2013 | 939 | 0.350 |
Why?
|
Hypertrophy, Left Ventricular | 6 | 2017 | 856 | 0.350 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2023 | 644 | 0.350 |
Why?
|
Heart Failure | 16 | 2023 | 11879 | 0.340 |
Why?
|
Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2010 | 131 | 0.340 |
Why?
|
Magnetic Resonance Imaging, Cine | 5 | 2023 | 1092 | 0.340 |
Why?
|
Models, Cardiovascular | 6 | 2019 | 983 | 0.340 |
Why?
|
Atrial Appendage | 2 | 2023 | 285 | 0.330 |
Why?
|
Severity of Illness Index | 24 | 2023 | 15955 | 0.330 |
Why?
|
Animals | 64 | 2023 | 169408 | 0.320 |
Why?
|
Middle Aged | 84 | 2025 | 223740 | 0.320 |
Why?
|
Female | 113 | 2025 | 397464 | 0.310 |
Why?
|
Aged | 72 | 2025 | 171790 | 0.290 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 3 | 2019 | 1141 | 0.280 |
Why?
|
Hypertrophy | 2 | 2013 | 562 | 0.280 |
Why?
|
Exercise Tolerance | 4 | 2019 | 846 | 0.260 |
Why?
|
Vestibulocochlear Nerve Diseases | 1 | 2006 | 33 | 0.260 |
Why?
|
Genes, Dominant | 2 | 2005 | 856 | 0.250 |
Why?
|
Death, Sudden, Cardiac | 2 | 2025 | 1568 | 0.250 |
Why?
|
Disease Progression | 11 | 2023 | 13677 | 0.240 |
Why?
|
Chromosomes, Human, Pair 13 | 1 | 2005 | 192 | 0.240 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2015 | 3411 | 0.240 |
Why?
|
Heart Valves | 4 | 2019 | 284 | 0.240 |
Why?
|
Epithelial-Mesenchymal Transition | 4 | 2022 | 755 | 0.240 |
Why?
|
Blood Pressure Monitors | 1 | 2004 | 33 | 0.230 |
Why?
|
Endocarditis | 1 | 2009 | 352 | 0.230 |
Why?
|
Nerve Compression Syndromes | 1 | 2006 | 160 | 0.230 |
Why?
|
Extracellular Matrix | 5 | 2020 | 1739 | 0.230 |
Why?
|
Cochlear Nerve | 1 | 2006 | 202 | 0.230 |
Why?
|
Losartan | 2 | 2017 | 262 | 0.230 |
Why?
|
Case-Control Studies | 16 | 2025 | 22294 | 0.220 |
Why?
|
Pedigree | 5 | 2025 | 4545 | 0.220 |
Why?
|
Artifacts | 2 | 2020 | 1942 | 0.220 |
Why?
|
Molecular Biology | 1 | 2007 | 573 | 0.220 |
Why?
|
Aged, 80 and over | 25 | 2022 | 59738 | 0.220 |
Why?
|
Oxygen Consumption | 2 | 2020 | 1883 | 0.210 |
Why?
|
Myocardium | 7 | 2022 | 4790 | 0.210 |
Why?
|
Sheep, Domestic | 3 | 2017 | 52 | 0.210 |
Why?
|
Polymers | 3 | 2017 | 1632 | 0.210 |
Why?
|
Cardiac Output | 4 | 2020 | 838 | 0.200 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2004 | 251 | 0.200 |
Why?
|
Rheumatic Fever | 1 | 2022 | 73 | 0.200 |
Why?
|
Thymosin | 1 | 2022 | 47 | 0.200 |
Why?
|
Cell Transdifferentiation | 2 | 2015 | 187 | 0.190 |
Why?
|
Pulmonary Edema | 1 | 2004 | 409 | 0.190 |
Why?
|
Coronary Occlusion | 2 | 2015 | 306 | 0.190 |
Why?
|
Image Processing, Computer-Assisted | 4 | 2010 | 9081 | 0.190 |
Why?
|
Transforming Growth Factor beta | 4 | 2017 | 2004 | 0.190 |
Why?
|
Image Enhancement | 3 | 2007 | 2898 | 0.180 |
Why?
|
Smad3 Protein | 2 | 2018 | 166 | 0.180 |
Why?
|
Treatment Outcome | 19 | 2024 | 65485 | 0.180 |
Why?
|
Heart Septum | 3 | 2010 | 304 | 0.170 |
Why?
|
Collagen Type I | 2 | 2022 | 620 | 0.170 |
Why?
|
Adult | 42 | 2025 | 223818 | 0.170 |
Why?
|
Magnetic Resonance Imaging | 10 | 2020 | 36861 | 0.170 |
Why?
|
Exhalation | 1 | 2020 | 185 | 0.170 |
Why?
|
Lymphatic Vessels | 1 | 2024 | 356 | 0.170 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2018 | 474 | 0.160 |
Why?
|
Aorta, Thoracic | 2 | 2017 | 1112 | 0.160 |
Why?
|
Echocardiography, Stress | 3 | 2016 | 139 | 0.160 |
Why?
|
Contractile Proteins | 2 | 2012 | 240 | 0.160 |
Why?
|
Angioplasty, Balloon | 1 | 2002 | 592 | 0.160 |
Why?
|
Prognosis | 14 | 2023 | 30044 | 0.150 |
Why?
|
Ultrasonography | 10 | 2015 | 6001 | 0.150 |
Why?
|
Time Factors | 16 | 2019 | 40266 | 0.150 |
Why?
|
Arrhythmias, Cardiac | 3 | 2023 | 2258 | 0.150 |
Why?
|
Observer Variation | 8 | 2016 | 2623 | 0.150 |
Why?
|
Stress, Mechanical | 6 | 2019 | 1680 | 0.150 |
Why?
|
Cardiac Surgical Procedures | 2 | 2017 | 3683 | 0.150 |
Why?
|
Estrogen Receptor alpha | 1 | 2022 | 581 | 0.150 |
Why?
|
Protein Precursors | 1 | 2022 | 1135 | 0.150 |
Why?
|
Follow-Up Studies | 15 | 2021 | 39394 | 0.140 |
Why?
|
Oximetry | 1 | 2020 | 462 | 0.140 |
Why?
|
Finite Element Analysis | 1 | 2019 | 442 | 0.140 |
Why?
|
Chromosome Mapping | 1 | 2005 | 4624 | 0.140 |
Why?
|
Organogenesis | 1 | 2018 | 214 | 0.140 |
Why?
|
Surgical Instruments | 1 | 2019 | 385 | 0.140 |
Why?
|
Reproducibility of Results | 16 | 2019 | 20244 | 0.130 |
Why?
|
Elastic Tissue | 1 | 2016 | 66 | 0.130 |
Why?
|
Cardiac Valve Annuloplasty | 1 | 2016 | 51 | 0.130 |
Why?
|
Phenotype | 12 | 2025 | 16735 | 0.130 |
Why?
|
Veins | 1 | 2020 | 769 | 0.130 |
Why?
|
Myocarditis | 1 | 2024 | 803 | 0.130 |
Why?
|
Analysis of Variance | 4 | 2017 | 6242 | 0.130 |
Why?
|
Retrospective Studies | 21 | 2023 | 81892 | 0.130 |
Why?
|
Brazil | 2 | 2017 | 1249 | 0.130 |
Why?
|
Collagen | 3 | 2022 | 2646 | 0.130 |
Why?
|
Prospective Studies | 15 | 2021 | 54950 | 0.130 |
Why?
|
Sarcomeres | 1 | 2018 | 380 | 0.130 |
Why?
|
Robotics | 1 | 2022 | 826 | 0.130 |
Why?
|
Auditory Threshold | 3 | 2012 | 369 | 0.130 |
Why?
|
Heart Septal Defects, Ventricular | 1 | 2018 | 477 | 0.130 |
Why?
|
Aortography | 1 | 2017 | 422 | 0.120 |
Why?
|
Risk Factors | 18 | 2025 | 74971 | 0.120 |
Why?
|
Transducers | 2 | 2008 | 245 | 0.120 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 2 | 2017 | 428 | 0.120 |
Why?
|
Risk Assessment | 10 | 2025 | 24330 | 0.120 |
Why?
|
Residence Characteristics | 2 | 2015 | 2122 | 0.120 |
Why?
|
Exercise | 3 | 2017 | 5953 | 0.120 |
Why?
|
Cilia | 1 | 2019 | 498 | 0.120 |
Why?
|
Surgical Mesh | 1 | 2017 | 316 | 0.120 |
Why?
|
Microfilament Proteins | 2 | 2012 | 1135 | 0.120 |
Why?
|
Galectin 3 | 1 | 2016 | 240 | 0.120 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 843 | 0.110 |
Why?
|
Audiometry, Pure-Tone | 2 | 2012 | 210 | 0.110 |
Why?
|
Family | 2 | 2015 | 3208 | 0.110 |
Why?
|
Bacteroidaceae Infections | 2 | 2004 | 32 | 0.110 |
Why?
|
Swine | 7 | 2023 | 5998 | 0.110 |
Why?
|
Heart Aneurysm | 2 | 2005 | 114 | 0.110 |
Why?
|
Inferior Wall Myocardial Infarction | 1 | 2013 | 10 | 0.110 |
Why?
|
Myofibroblasts | 1 | 2015 | 230 | 0.110 |
Why?
|
Injections | 3 | 2015 | 841 | 0.100 |
Why?
|
Bradycardia | 1 | 2014 | 305 | 0.100 |
Why?
|
Coronary Artery Disease | 3 | 2019 | 6569 | 0.100 |
Why?
|
Rupture | 1 | 2014 | 444 | 0.100 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2013 | 139 | 0.100 |
Why?
|
Acoustic Stimulation | 3 | 2012 | 1256 | 0.100 |
Why?
|
Organ Size | 3 | 2019 | 2268 | 0.100 |
Why?
|
Intracranial Embolism | 1 | 2014 | 189 | 0.100 |
Why?
|
Anterior Wall Myocardial Infarction | 1 | 2013 | 42 | 0.100 |
Why?
|
Ventricular Dysfunction | 1 | 2013 | 144 | 0.100 |
Why?
|
Pacemaker, Artificial | 2 | 2021 | 828 | 0.100 |
Why?
|
Pulmonary Wedge Pressure | 1 | 2013 | 275 | 0.100 |
Why?
|
Blood Pressure | 4 | 2020 | 8541 | 0.100 |
Why?
|
Cardiomyopathies | 3 | 2021 | 2057 | 0.100 |
Why?
|
Cochlear Nucleus | 1 | 2012 | 62 | 0.100 |
Why?
|
Troponin I | 1 | 2016 | 662 | 0.100 |
Why?
|
Myxoma | 1 | 2012 | 114 | 0.100 |
Why?
|
Otoacoustic Emissions, Spontaneous | 1 | 2012 | 139 | 0.090 |
Why?
|
Cardiomyopathy, Hypertrophic, Familial | 1 | 2011 | 63 | 0.090 |
Why?
|
Postoperative Complications | 2 | 2012 | 15889 | 0.090 |
Why?
|
Heart | 4 | 2019 | 4448 | 0.090 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2012 | 255 | 0.090 |
Why?
|
Perceptual Distortion | 1 | 2010 | 36 | 0.090 |
Why?
|
Tricuspid Valve | 3 | 2021 | 419 | 0.090 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 2 | 2015 | 1232 | 0.090 |
Why?
|
Cells, Cultured | 5 | 2022 | 19023 | 0.090 |
Why?
|
Cadherins | 1 | 2015 | 906 | 0.090 |
Why?
|
Blood Flow Velocity | 4 | 2011 | 1376 | 0.090 |
Why?
|
Matrix Metalloproteinases | 2 | 2016 | 393 | 0.090 |
Why?
|
Hyperacusis | 1 | 2010 | 31 | 0.090 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2020 | 1514 | 0.090 |
Why?
|
Ventricular Pressure | 3 | 2022 | 210 | 0.090 |
Why?
|
Ligation | 1 | 2011 | 446 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6546 | 0.090 |
Why?
|
Aortic Diseases | 2 | 2014 | 741 | 0.090 |
Why?
|
Chi-Square Distribution | 4 | 2013 | 3438 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 5 | 2020 | 20776 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 5 | 2025 | 18065 | 0.080 |
Why?
|
Models, Animal | 3 | 2011 | 2123 | 0.080 |
Why?
|
Ischemia | 3 | 2022 | 1900 | 0.080 |
Why?
|
Arteriosclerosis | 2 | 2004 | 1056 | 0.080 |
Why?
|
Oxygen | 1 | 2020 | 4273 | 0.080 |
Why?
|
Inferior Colliculi | 1 | 2009 | 79 | 0.080 |
Why?
|
Biopsy | 2 | 2017 | 6805 | 0.080 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2015 | 411 | 0.080 |
Why?
|
Chronic Disease | 6 | 2013 | 9384 | 0.080 |
Why?
|
Stress, Psychological | 1 | 2004 | 4542 | 0.080 |
Why?
|
Pulsatile Flow | 1 | 2009 | 320 | 0.080 |
Why?
|
Mesencephalon | 1 | 2010 | 339 | 0.080 |
Why?
|
Genetic Diseases, X-Linked | 1 | 2012 | 391 | 0.080 |
Why?
|
Diastole | 3 | 2019 | 784 | 0.080 |
Why?
|
Cell Proliferation | 4 | 2017 | 10486 | 0.080 |
Why?
|
Genes, Reporter | 2 | 2010 | 1524 | 0.080 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2010 | 262 | 0.080 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4651 | 0.070 |
Why?
|
Prosthesis Design | 4 | 2019 | 2126 | 0.070 |
Why?
|
Equipment Design | 3 | 2017 | 3529 | 0.070 |
Why?
|
Phantoms, Imaging | 2 | 2008 | 2533 | 0.070 |
Why?
|
Software | 2 | 2015 | 4480 | 0.070 |
Why?
|
Japan | 3 | 2020 | 1418 | 0.070 |
Why?
|
Cell Communication | 1 | 2015 | 1660 | 0.070 |
Why?
|
Auditory Pathways | 1 | 2009 | 238 | 0.070 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2016 | 1751 | 0.070 |
Why?
|
Gels | 1 | 2008 | 422 | 0.070 |
Why?
|
Heart Rate | 4 | 2012 | 4217 | 0.070 |
Why?
|
Hypertension | 2 | 2004 | 8615 | 0.070 |
Why?
|
Recurrence | 5 | 2021 | 8512 | 0.070 |
Why?
|
Forecasting | 1 | 2016 | 2946 | 0.070 |
Why?
|
Corpus Callosum | 1 | 2012 | 754 | 0.070 |
Why?
|
Muscle Cells | 1 | 2008 | 195 | 0.070 |
Why?
|
Physical Exertion | 1 | 2010 | 668 | 0.070 |
Why?
|
MAP Kinase Signaling System | 1 | 2014 | 1494 | 0.070 |
Why?
|
Cause of Death | 1 | 2017 | 3721 | 0.070 |
Why?
|
Genetic Research | 1 | 2007 | 173 | 0.070 |
Why?
|
Evoked Potentials, Auditory | 1 | 2009 | 533 | 0.070 |
Why?
|
Up-Regulation | 2 | 2017 | 4148 | 0.060 |
Why?
|
Proportional Hazards Models | 2 | 2018 | 12563 | 0.060 |
Why?
|
Myoblasts, Skeletal | 1 | 2006 | 74 | 0.060 |
Why?
|
Cytomegalovirus | 1 | 2010 | 753 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2010 | 1169 | 0.060 |
Why?
|
Mutation | 4 | 2018 | 30266 | 0.060 |
Why?
|
Automation | 1 | 2008 | 589 | 0.060 |
Why?
|
Contrast Media | 3 | 2023 | 5334 | 0.060 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2009 | 881 | 0.060 |
Why?
|
Osteoblasts | 1 | 2010 | 1153 | 0.060 |
Why?
|
Gene Transfer Techniques | 1 | 2010 | 1209 | 0.060 |
Why?
|
Carbamazepine | 1 | 2006 | 224 | 0.060 |
Why?
|
Dependovirus | 1 | 2010 | 721 | 0.060 |
Why?
|
Mathematical Computing | 1 | 2005 | 142 | 0.060 |
Why?
|
Porphyromonas gingivalis | 2 | 2004 | 165 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 2 | 2022 | 2892 | 0.060 |
Why?
|
Brain | 1 | 2012 | 27476 | 0.060 |
Why?
|
Lod Score | 1 | 2005 | 600 | 0.060 |
Why?
|
Gadolinium DTPA | 1 | 2008 | 823 | 0.060 |
Why?
|
Dilatation, Pathologic | 3 | 2014 | 527 | 0.060 |
Why?
|
Multivariate Analysis | 5 | 2017 | 12093 | 0.060 |
Why?
|
Electrocardiography | 3 | 2012 | 6413 | 0.060 |
Why?
|
Genetic Heterogeneity | 2 | 2005 | 737 | 0.060 |
Why?
|
Hydrogels | 1 | 2010 | 745 | 0.060 |
Why?
|
Sex Factors | 4 | 2023 | 10641 | 0.060 |
Why?
|
Heredity | 1 | 2025 | 149 | 0.060 |
Why?
|
Boston | 1 | 2017 | 9375 | 0.060 |
Why?
|
Sensitivity and Specificity | 7 | 2017 | 14751 | 0.060 |
Why?
|
Thalamus | 1 | 2010 | 1050 | 0.060 |
Why?
|
Cell Transplantation | 1 | 2006 | 475 | 0.060 |
Why?
|
Statistics, Nonparametric | 3 | 2018 | 2862 | 0.060 |
Why?
|
Logistic Models | 4 | 2015 | 13317 | 0.060 |
Why?
|
Recovery of Function | 3 | 2019 | 2990 | 0.060 |
Why?
|
Osteogenesis | 1 | 2010 | 1295 | 0.060 |
Why?
|
Anthropometry | 2 | 2012 | 1343 | 0.050 |
Why?
|
Peptide Fragments | 1 | 2016 | 5150 | 0.050 |
Why?
|
Blood Volume | 1 | 2005 | 546 | 0.050 |
Why?
|
Receptors, Interleukin-1 | 1 | 2004 | 260 | 0.050 |
Why?
|
Heterozygote | 2 | 2018 | 2798 | 0.050 |
Why?
|
Serotonin | 2 | 2022 | 1045 | 0.050 |
Why?
|
Rome | 1 | 2022 | 28 | 0.050 |
Why?
|
Extracellular Matrix Proteins | 1 | 2007 | 835 | 0.050 |
Why?
|
Illusions | 1 | 2003 | 61 | 0.050 |
Why?
|
Cyproheptadine | 1 | 2022 | 21 | 0.050 |
Why?
|
Genetic Linkage | 2 | 2005 | 2342 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2015 | 3709 | 0.050 |
Why?
|
Lymphangiogenesis | 1 | 2024 | 171 | 0.050 |
Why?
|
Genome-Wide Association Study | 5 | 2022 | 12798 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2022 | 45 | 0.050 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2017 | 642 | 0.050 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2025 | 582 | 0.050 |
Why?
|
Calcium | 2 | 2022 | 5792 | 0.050 |
Why?
|
Tachycardia | 1 | 2004 | 599 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2019 | 9618 | 0.050 |
Why?
|
Prostheses and Implants | 1 | 2008 | 1279 | 0.050 |
Why?
|
Terrorism | 1 | 2004 | 211 | 0.050 |
Why?
|
Cohort Studies | 6 | 2018 | 41800 | 0.050 |
Why?
|
Coronary Artery Bypass | 3 | 2006 | 2194 | 0.050 |
Why?
|
Infarction | 1 | 2022 | 247 | 0.040 |
Why?
|
Decompression, Surgical | 1 | 2006 | 610 | 0.040 |
Why?
|
Interleukin-1 | 1 | 2004 | 1251 | 0.040 |
Why?
|
Mice, Knockout | 5 | 2019 | 14485 | 0.040 |
Why?
|
Linear Models | 3 | 2017 | 5890 | 0.040 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2003 | 452 | 0.040 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2007 | 1658 | 0.040 |
Why?
|
Apolipoproteins E | 2 | 2004 | 1461 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2010 | 1459 | 0.040 |
Why?
|
Coronary Vessels | 1 | 2011 | 3124 | 0.040 |
Why?
|
Aging | 2 | 2017 | 8765 | 0.040 |
Why?
|
Endothelium | 1 | 2022 | 768 | 0.040 |
Why?
|
Transcription Factors | 1 | 2019 | 12174 | 0.040 |
Why?
|
Breath Tests | 1 | 2020 | 300 | 0.040 |
Why?
|
Mice | 9 | 2021 | 82074 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2010 | 5801 | 0.040 |
Why?
|
Compliance | 1 | 2018 | 100 | 0.040 |
Why?
|
Survival Analysis | 2 | 2016 | 10115 | 0.040 |
Why?
|
Tissue Survival | 1 | 2018 | 120 | 0.040 |
Why?
|
Heart Defects, Congenital | 2 | 2012 | 4711 | 0.040 |
Why?
|
Gadolinium | 1 | 2023 | 965 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11934 | 0.040 |
Why?
|
Proteomics | 2 | 2022 | 3913 | 0.040 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2022 | 827 | 0.040 |
Why?
|
Heart Function Tests | 1 | 2019 | 317 | 0.040 |
Why?
|
Patient Selection | 2 | 2007 | 4265 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2005 | 1541 | 0.040 |
Why?
|
Stem Cells | 1 | 2010 | 3540 | 0.040 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2005 | 1495 | 0.040 |
Why?
|
Prevalence | 4 | 2020 | 15875 | 0.040 |
Why?
|
Cardiac Output, Low | 1 | 2018 | 192 | 0.040 |
Why?
|
Endocardium | 2 | 2012 | 249 | 0.040 |
Why?
|
Perfusion | 1 | 2022 | 1402 | 0.040 |
Why?
|
Diagnostic Errors | 1 | 2004 | 1281 | 0.030 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2008 | 2831 | 0.030 |
Why?
|
Massachusetts | 2 | 2016 | 8888 | 0.030 |
Why?
|
Dietary Fats | 1 | 2004 | 2003 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2022 | 3056 | 0.030 |
Why?
|
Registries | 3 | 2020 | 8384 | 0.030 |
Why?
|
Radiography | 1 | 2007 | 6991 | 0.030 |
Why?
|
Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography | 1 | 2015 | 6 | 0.030 |
Why?
|
Genetic Markers | 2 | 2018 | 2604 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2022 | 1476 | 0.030 |
Why?
|
Least-Squares Analysis | 1 | 2016 | 367 | 0.030 |
Why?
|
Motion | 2 | 2012 | 794 | 0.030 |
Why?
|
Zebrafish | 2 | 2019 | 3037 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2022 | 1363 | 0.030 |
Why?
|
Morphogenesis | 1 | 2019 | 747 | 0.030 |
Why?
|
France | 1 | 2016 | 497 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1794 | 0.030 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2017 | 462 | 0.030 |
Why?
|
Elastin | 1 | 2016 | 299 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1855 | 0.030 |
Why?
|
Statistics as Topic | 2 | 2016 | 2359 | 0.030 |
Why?
|
Random Allocation | 2 | 2012 | 2396 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 628 | 0.030 |
Why?
|
Antigens, CD34 | 1 | 2016 | 656 | 0.030 |
Why?
|
New York City | 1 | 2016 | 737 | 0.030 |
Why?
|
Receptors, Angiotensin | 1 | 2014 | 141 | 0.030 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2020 | 1064 | 0.030 |
Why?
|
Psychological Techniques | 1 | 2013 | 48 | 0.030 |
Why?
|
Diet, Atherogenic | 2 | 2004 | 92 | 0.030 |
Why?
|
Protein Stability | 1 | 2015 | 580 | 0.030 |
Why?
|
Acute Disease | 1 | 2004 | 7245 | 0.030 |
Why?
|
Functional Laterality | 2 | 2010 | 2269 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2017 | 1890 | 0.030 |
Why?
|
Algorithms | 2 | 2020 | 14199 | 0.030 |
Why?
|
Genetic Loci | 1 | 2022 | 2630 | 0.030 |
Why?
|
Endocardial Cushions | 1 | 2012 | 12 | 0.030 |
Why?
|
Thrombosis | 1 | 2006 | 2956 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2023 | 2660 | 0.030 |
Why?
|
Cell Lineage | 2 | 2012 | 2576 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 478 | 0.020 |
Why?
|
Tryptophan Hydroxylase | 1 | 2012 | 94 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2022 | 3782 | 0.020 |
Why?
|
Models, Molecular | 1 | 2022 | 5404 | 0.020 |
Why?
|
Proteome | 1 | 2022 | 1891 | 0.020 |
Why?
|
Cell Movement | 2 | 2015 | 5216 | 0.020 |
Why?
|
New York | 1 | 2014 | 884 | 0.020 |
Why?
|
Signal Transduction | 3 | 2016 | 23652 | 0.020 |
Why?
|
Heart Diseases | 1 | 2004 | 2819 | 0.020 |
Why?
|
Syndrome | 1 | 2018 | 3274 | 0.020 |
Why?
|
Ambulatory Care | 1 | 2002 | 2783 | 0.020 |
Why?
|
Captopril | 1 | 2012 | 262 | 0.020 |
Why?
|
Defibrillators, Implantable | 1 | 2021 | 1498 | 0.020 |
Why?
|
Transglutaminases | 1 | 2012 | 200 | 0.020 |
Why?
|
Pulmonary Artery | 1 | 2020 | 1945 | 0.020 |
Why?
|
Body Patterning | 1 | 2015 | 634 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2015 | 1342 | 0.020 |
Why?
|
Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 327 | 0.020 |
Why?
|
Valine | 1 | 2012 | 410 | 0.020 |
Why?
|
Chick Embryo | 1 | 2012 | 975 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2022 | 13427 | 0.020 |
Why?
|
Osteocalcin | 1 | 2010 | 277 | 0.020 |
Why?
|
Sus scrofa | 1 | 2011 | 430 | 0.020 |
Why?
|
Immunophenotyping | 1 | 2015 | 1866 | 0.020 |
Why?
|
Computational Biology | 1 | 2022 | 3562 | 0.020 |
Why?
|
Stroke | 2 | 2021 | 9756 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1585 | 0.020 |
Why?
|
Actins | 1 | 2017 | 2065 | 0.020 |
Why?
|
Protein Binding | 1 | 2022 | 9344 | 0.020 |
Why?
|
Sound Spectrography | 1 | 2009 | 114 | 0.020 |
Why?
|
Perceptual Masking | 1 | 2009 | 90 | 0.020 |
Why?
|
Chondrogenesis | 1 | 2010 | 239 | 0.020 |
Why?
|
Zebrafish Proteins | 1 | 2015 | 1019 | 0.020 |
Why?
|
Mesoderm | 1 | 2012 | 679 | 0.020 |
Why?
|
Tumor Suppressor Proteins | 1 | 2019 | 2813 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2019 | 2911 | 0.020 |
Why?
|
Sex Distribution | 1 | 2013 | 2280 | 0.020 |
Why?
|
Genotype | 2 | 2018 | 13048 | 0.020 |
Why?
|
Base Sequence | 1 | 2019 | 12430 | 0.020 |
Why?
|
Adipogenesis | 1 | 2010 | 371 | 0.020 |
Why?
|
GTP-Binding Proteins | 1 | 2012 | 947 | 0.020 |
Why?
|
Age Factors | 2 | 2017 | 18454 | 0.020 |
Why?
|
Age Distribution | 1 | 2013 | 2875 | 0.020 |
Why?
|
Remission Induction | 1 | 2013 | 2411 | 0.020 |
Why?
|
Coronary Disease | 1 | 2002 | 5919 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2014 | 2730 | 0.020 |
Why?
|
Ventricular Septum | 1 | 2007 | 76 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2016 | 11119 | 0.020 |
Why?
|
Noise | 1 | 2009 | 295 | 0.020 |
Why?
|
Computer Systems | 1 | 2008 | 470 | 0.020 |
Why?
|
Incidence | 3 | 2014 | 21545 | 0.020 |
Why?
|
Tetrazoles | 1 | 2012 | 923 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6289 | 0.020 |
Why?
|
Models, Biological | 1 | 2022 | 9499 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2006 | 280 | 0.020 |
Why?
|
Young Adult | 3 | 2018 | 60110 | 0.010 |
Why?
|
Reference Values | 1 | 2012 | 4941 | 0.010 |
Why?
|
Serum Amyloid A Protein | 1 | 2004 | 128 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2014 | 6512 | 0.010 |
Why?
|
Monitoring, Physiologic | 1 | 2012 | 1796 | 0.010 |
Why?
|
ROC Curve | 1 | 2012 | 3629 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12873 | 0.010 |
Why?
|
Postoperative Period | 1 | 2008 | 1830 | 0.010 |
Why?
|
Movement Disorders | 1 | 2007 | 464 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2014 | 5323 | 0.010 |
Why?
|
Phosphorylation | 1 | 2014 | 8317 | 0.010 |
Why?
|
Injections, Intra-Arterial | 1 | 2002 | 181 | 0.010 |
Why?
|
Founder Effect | 1 | 2003 | 185 | 0.010 |
Why?
|
Coronary Angiography | 1 | 2014 | 4541 | 0.010 |
Why?
|
Sinus of Valsalva | 1 | 2002 | 60 | 0.010 |
Why?
|
Pulmonary Valve Insufficiency | 1 | 2003 | 140 | 0.010 |
Why?
|
Fibroblasts | 1 | 2012 | 4178 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2005 | 1502 | 0.010 |
Why?
|
beta-Galactosidase | 1 | 2002 | 575 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2002 | 26384 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2006 | 2126 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 10845 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2002 | 1163 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9682 | 0.010 |
Why?
|
Acetylcholine | 1 | 2002 | 629 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12809 | 0.010 |
Why?
|
Cicatrix | 1 | 2006 | 799 | 0.010 |
Why?
|
Treatment Failure | 1 | 2006 | 2663 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16051 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2016 | 14795 | 0.010 |
Why?
|
Pericardium | 1 | 2003 | 679 | 0.010 |
Why?
|
Adenoviridae | 1 | 2002 | 1095 | 0.010 |
Why?
|
Carotid Arteries | 1 | 2002 | 943 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2002 | 990 | 0.010 |
Why?
|
Drug Carriers | 1 | 2002 | 710 | 0.010 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2002 | 1048 | 0.010 |
Why?
|
Organ Specificity | 1 | 2002 | 1970 | 0.010 |
Why?
|
Catheterization | 1 | 2002 | 1431 | 0.010 |
Why?
|
Fluorocarbons | 1 | 2002 | 506 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 2002 | 1478 | 0.010 |
Why?
|
Dogs | 1 | 2002 | 3845 | 0.010 |
Why?
|
Haplotypes | 1 | 2003 | 2725 | 0.010 |
Why?
|
Anxiety | 1 | 2010 | 4677 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2012 | 11684 | 0.010 |
Why?
|
Catheter Ablation | 1 | 2007 | 2780 | 0.010 |
Why?
|
Aorta | 1 | 2002 | 2046 | 0.010 |
Why?
|
Brain Mapping | 1 | 2009 | 6740 | 0.010 |
Why?
|
Adolescent | 2 | 2018 | 89247 | 0.010 |
Why?
|
Regression Analysis | 1 | 2003 | 6346 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2002 | 3414 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2002 | 6085 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2007 | 13020 | 0.010 |
Why?
|
Depression | 1 | 2010 | 8240 | 0.010 |
Why?
|
Genetic Testing | 1 | 2003 | 3590 | 0.010 |
Why?
|
Gene Expression | 1 | 2002 | 7602 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2003 | 3008 | 0.010 |
Why?
|
Databases, Factual | 1 | 2005 | 8095 | 0.010 |
Why?
|
Artificial Intelligence | 1 | 2003 | 2665 | 0.000 |
Why?
|
Rats | 1 | 2002 | 23847 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 22381 | 0.000 |
Why?
|
Child, Preschool | 1 | 2003 | 42684 | 0.000 |
Why?
|
Child | 1 | 2003 | 80969 | 0.000 |
Why?
|